Evaxion EVAX Stock
Evaxion Price Chart
Evaxion EVAX Financial and Trading Overview
| Evaxion stock price | 3.76 USD |
| Previous Close | 3.71 USD |
| Open | 3.96 USD |
| Bid | 4 USD x 200 |
| Ask | 4.09 USD x 200 |
| Day's Range | 3.65 - 4 USD |
| 52 Week Range | 2.72 - 6.92 USD |
| Volume | 161.65K USD |
| Avg. Volume | 228.72K USD |
| Market Cap | 33.92M USD |
| Beta (5Y Monthly) | 0.511 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.25 USD |
EVAX Valuation Measures
| Enterprise Value | 24.46M USD |
| Trailing P/E | N/A |
| Forward P/E | -250.66667 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.528204 |
| Price/Book (mrq) | 3.2895887 |
| Enterprise Value/Revenue | 3.266 |
| Enterprise Value/EBITDA | -2.938 |
Trading Information
Evaxion Stock Price History
| Beta (5Y Monthly) | 0.511 |
| 52-Week Change | -38.66% |
| S&P500 52-Week Change | 10.88% |
| 52 Week High | 6.92 USD |
| 52 Week Low | 2.72 USD |
| 50-Day Moving Average | 3.2 USD |
| 200-Day Moving Average | 3.55 USD |
EVAX Share Statistics
| Avg. Volume (3 month) | 228.72K USD |
| Avg. Daily Volume (10-Days) | 194.74K USD |
| Shares Outstanding | 9.02M |
| Float | 5.68M |
| Short Ratio | 1.06 |
| % Held by Insiders | 16.14% |
| % Held by Institutions | 9.41% |
| Shares Short | 50.58K |
| Short % of Float | 0.67% |
| Short % of Shares Outstanding | 0.55% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -115.53% |
| Operating Margin (ttm) | -116.019% |
| Gross Margin | 100.00% |
| EBITDA Margin | -111.14% |
Management Effectiveness
| Return on Assets (ttm) | -25.97% |
| Return on Equity (ttm) | -109.85% |
Income Statement
| Revenue (ttm) | 7.49M USD |
| Revenue Per Share (ttm) | 0.94 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 7.49M USD |
| EBITDA | -8326000 USD |
| Net Income Avi to Common (ttm) | -8655000 USD |
| Diluted EPS (ttm) | -1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14M USD |
| Total Cash Per Share (mrq) | 1.68 USD |
| Total Debt (mrq) | 7.11M USD |
| Total Debt/Equity (mrq) | 74.55 USD |
| Current Ratio (mrq) | 5.062 |
| Book Value Per Share (mrq) | 1.143 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7164000 USD |
| Levered Free Cash Flow (ttm) | -5487625 USD |
Profile of Evaxion
| Country | United States |
| State | N/A |
| City | Horsholm |
| Address | Dr. Neergaards Vej |
| ZIP | 2970 |
| Phone | 45 53 53 18 50 |
| Website | https://evaxion.ai |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 46 |
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a multi-component prophylactic vaccine targeting skin and soft tissue infections with S. aureus bacteria; EVX-B2 to target multi-component prophylactic vaccine against gonorrhea bacteria; EVX-B3 to target bacterial pathogen associated with repeated infections; and EVX-V1, a multi-component prophylactic vaccine candidate for cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.
Q&A For Evaxion Stock
What is a current EVAX stock price?
Evaxion EVAX stock price today per share is 3.76 USD.
How to purchase Evaxion stock?
You can buy EVAX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evaxion?
The stock symbol or ticker of Evaxion is EVAX.
Which industry does the Evaxion company belong to?
The Evaxion industry is Biotechnology.
How many shares does Evaxion have in circulation?
The max supply of Evaxion shares is 9.02M.
What is Evaxion Price to Earnings Ratio (PE Ratio)?
Evaxion PE Ratio is now.
What was Evaxion earnings per share over the trailing 12 months (TTM)?
Evaxion EPS is -1 USD over the trailing 12 months.
Which sector does the Evaxion company belong to?
The Evaxion sector is Healthcare.
Evaxion EVAX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25955.34 USD — |
-0.21
|
5.73B USD — | 25866.15 USD — | 26111.62 USD — | — - | 5.73B USD — |
|
US Tech Health Care
IXHC
US
|
1327.92 USD — |
-0.97
|
— — | 1320.94 USD — | 1335.06 USD — | — - | — — |
- {{ link.label }} {{link}}
